Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs

Synergistic effects of doxorubicin and vincristine

John Wong, Lisa T. Tran, Eli A. Magun, Bruce E. Magun, Lisa Wood

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cytotoxic chemotherapeutic drugs, especially when used in combination, are widely employed to treat a variety of cancers in patients but often lead to serious symptoms that negatively affect physical functioning and quality of life. There is compelling evidence that implicates cytotoxic chemotherapy-induced inflammation in the etiology of these symptoms. Because IL-1β plays a central role as an initiator cytokine in immune responses, we compared doxorubicin, a drug known to induce IL-1β production, with ten other commonly prescribed chemotherapeutic drugs in their ability to lead to processing and secretion of IL-1β by primary mouse macrophages. Seven of them (melphalan, cisplatin, vincristine, etoposide, paclitaxel, methotrexate, and cytarabine) caused the production of IL-1β in cells pretreated with lipopolysaccharide. When delivered in combination with doxorubicin, one of the drugs, vincristine, was also capable of synergistically activating the NLRP3-dependent inflammasome and increasing expression of IL-1β, IL-6, and CXCL1. The absence of TNF-α and IL-1 signaling caused a partial reduction in the production of mature IL-1β. Three small-molecule inhibitors known to suppress activity of kinases situated upstream of mitogen-activated kinases (MAPKs) inhibited the expression of IL-1β, IL-6, and CXCL1 when doxorubicin and vincristine were used singly or together, so specific kinase inhibitors may be useful in reducing inflammation in patients receiving chemotherapy.

Original languageEnglish (US)
Pages (from-to)1395-1403
Number of pages9
JournalCancer Biology and Therapy
Volume15
Issue number10
DOIs
StatePublished - Oct 1 2014
Externally publishedYes

Fingerprint

Vincristine
Interleukin-1
Doxorubicin
Macrophages
Pharmaceutical Preparations
Interleukin-6
Phosphotransferases
Inflammasomes
Inflammation
Drug Therapy
Melphalan
Cytarabine
Mitogen-Activated Protein Kinase Kinases
Etoposide
Paclitaxel
Mitogens
Methotrexate
Cisplatin
Lipopolysaccharides
Quality of Life

Keywords

  • Cytokines
  • Inflammasome
  • Nilotinib
  • Ponatinib
  • Sorafenib

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs : Synergistic effects of doxorubicin and vincristine. / Wong, John; Tran, Lisa T.; Magun, Eli A.; Magun, Bruce E.; Wood, Lisa.

In: Cancer Biology and Therapy, Vol. 15, No. 10, 01.10.2014, p. 1395-1403.

Research output: Contribution to journalArticle

Wong, John ; Tran, Lisa T. ; Magun, Eli A. ; Magun, Bruce E. ; Wood, Lisa. / Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs : Synergistic effects of doxorubicin and vincristine. In: Cancer Biology and Therapy. 2014 ; Vol. 15, No. 10. pp. 1395-1403.
@article{5ee0362900a84b2b957f749a01c3fbc5,
title = "Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: Synergistic effects of doxorubicin and vincristine",
abstract = "Cytotoxic chemotherapeutic drugs, especially when used in combination, are widely employed to treat a variety of cancers in patients but often lead to serious symptoms that negatively affect physical functioning and quality of life. There is compelling evidence that implicates cytotoxic chemotherapy-induced inflammation in the etiology of these symptoms. Because IL-1β plays a central role as an initiator cytokine in immune responses, we compared doxorubicin, a drug known to induce IL-1β production, with ten other commonly prescribed chemotherapeutic drugs in their ability to lead to processing and secretion of IL-1β by primary mouse macrophages. Seven of them (melphalan, cisplatin, vincristine, etoposide, paclitaxel, methotrexate, and cytarabine) caused the production of IL-1β in cells pretreated with lipopolysaccharide. When delivered in combination with doxorubicin, one of the drugs, vincristine, was also capable of synergistically activating the NLRP3-dependent inflammasome and increasing expression of IL-1β, IL-6, and CXCL1. The absence of TNF-α and IL-1 signaling caused a partial reduction in the production of mature IL-1β. Three small-molecule inhibitors known to suppress activity of kinases situated upstream of mitogen-activated kinases (MAPKs) inhibited the expression of IL-1β, IL-6, and CXCL1 when doxorubicin and vincristine were used singly or together, so specific kinase inhibitors may be useful in reducing inflammation in patients receiving chemotherapy.",
keywords = "Cytokines, Inflammasome, Nilotinib, Ponatinib, Sorafenib",
author = "John Wong and Tran, {Lisa T.} and Magun, {Eli A.} and Magun, {Bruce E.} and Lisa Wood",
year = "2014",
month = "10",
day = "1",
doi = "10.4161/cbt.29922",
language = "English (US)",
volume = "15",
pages = "1395--1403",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "10",

}

TY - JOUR

T1 - Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs

T2 - Synergistic effects of doxorubicin and vincristine

AU - Wong, John

AU - Tran, Lisa T.

AU - Magun, Eli A.

AU - Magun, Bruce E.

AU - Wood, Lisa

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Cytotoxic chemotherapeutic drugs, especially when used in combination, are widely employed to treat a variety of cancers in patients but often lead to serious symptoms that negatively affect physical functioning and quality of life. There is compelling evidence that implicates cytotoxic chemotherapy-induced inflammation in the etiology of these symptoms. Because IL-1β plays a central role as an initiator cytokine in immune responses, we compared doxorubicin, a drug known to induce IL-1β production, with ten other commonly prescribed chemotherapeutic drugs in their ability to lead to processing and secretion of IL-1β by primary mouse macrophages. Seven of them (melphalan, cisplatin, vincristine, etoposide, paclitaxel, methotrexate, and cytarabine) caused the production of IL-1β in cells pretreated with lipopolysaccharide. When delivered in combination with doxorubicin, one of the drugs, vincristine, was also capable of synergistically activating the NLRP3-dependent inflammasome and increasing expression of IL-1β, IL-6, and CXCL1. The absence of TNF-α and IL-1 signaling caused a partial reduction in the production of mature IL-1β. Three small-molecule inhibitors known to suppress activity of kinases situated upstream of mitogen-activated kinases (MAPKs) inhibited the expression of IL-1β, IL-6, and CXCL1 when doxorubicin and vincristine were used singly or together, so specific kinase inhibitors may be useful in reducing inflammation in patients receiving chemotherapy.

AB - Cytotoxic chemotherapeutic drugs, especially when used in combination, are widely employed to treat a variety of cancers in patients but often lead to serious symptoms that negatively affect physical functioning and quality of life. There is compelling evidence that implicates cytotoxic chemotherapy-induced inflammation in the etiology of these symptoms. Because IL-1β plays a central role as an initiator cytokine in immune responses, we compared doxorubicin, a drug known to induce IL-1β production, with ten other commonly prescribed chemotherapeutic drugs in their ability to lead to processing and secretion of IL-1β by primary mouse macrophages. Seven of them (melphalan, cisplatin, vincristine, etoposide, paclitaxel, methotrexate, and cytarabine) caused the production of IL-1β in cells pretreated with lipopolysaccharide. When delivered in combination with doxorubicin, one of the drugs, vincristine, was also capable of synergistically activating the NLRP3-dependent inflammasome and increasing expression of IL-1β, IL-6, and CXCL1. The absence of TNF-α and IL-1 signaling caused a partial reduction in the production of mature IL-1β. Three small-molecule inhibitors known to suppress activity of kinases situated upstream of mitogen-activated kinases (MAPKs) inhibited the expression of IL-1β, IL-6, and CXCL1 when doxorubicin and vincristine were used singly or together, so specific kinase inhibitors may be useful in reducing inflammation in patients receiving chemotherapy.

KW - Cytokines

KW - Inflammasome

KW - Nilotinib

KW - Ponatinib

KW - Sorafenib

UR - http://www.scopus.com/inward/record.url?scp=84908448584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908448584&partnerID=8YFLogxK

U2 - 10.4161/cbt.29922

DO - 10.4161/cbt.29922

M3 - Article

VL - 15

SP - 1395

EP - 1403

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 10

ER -